Interestingly, scRNA-seq analysis of melanoma patients treated with immunotherapy demonstrated that TREM2+ TAMs were linked to immunotherapy modulation, which exhibited a similar gene signature to TREM2+ TAMs in ESCC. Here, TREM2 is linked to melanoma.